Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で6789.73%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 615.87Kに達しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 615.87Kです。
適正水準
同社の最新のPEは-0.62で、過去3年間の水準と比較して適正圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は292.25K株で、前四半期比で33.05%増加しています。
ジェームズ・シモンズが保有
スター投資家ジェームズ・シモンズは本銘柄を31.00K株保有しています。